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A reference monoclonal antibody IgG1 and a fusion IgG protein
were analyzed by top- and middle-down mass spectrometry with
multiple fragmentation techniques including electron transfer
dissociation (ETD) and matrix-assisted laser desorption ionization
in-source decay (MALDI-ISD) to investigate heterogeneity of gly-
cosylated protein species. Speciﬁcally, glycan structure, sites,
relative abundance levels, and termini structural conformation
were investigated by use of Fourier transform ion cyclotron reso-
nance (FT-ICR) or high performance liquid chromatography elec-
trospray ionization (HPLC-ESI) linked to an Orbitrap. Incorporating
a limited enzymatic digestion by immunoglobulin G-degrading
enzyme Streptococcus pyogenes (IdeS) with MALDI-ISD analysis
extended sequence coverage of the internal region of the proteins
without pre-fractionation. The data in this article is associated
with the research article published in Journal of Proteomics (Tran
et al., 2015) [1].
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.jprot.2015.10.021
(D.R. Goodlett), ygoo@rx.umaryland.edu (Y.A. Goo).
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ject areaTop- and middle-down mass spectrometric analysis of protein species and
proteoformsype of data Table, Figure
ow data was
acquiredMass spectrometry data were collected on a 12TFT-ICR XR (Bruker) and a
LTQ-Orbitrap Elite (Thermo Scientiﬁc)ata format MS spectra
xperimental
factorsTop- and middle-down analyses with multiple fragmentation techniques
including electron transfer dissociation (ETD) and matrix-assisted laser
desorption ionization in-source decay (MALDI-ISD) for characterization of a
reference monoclonal antibody IgG1 and a fusion IgG proteinxperimental
featuresGlycan proﬁling including structure, sites, relative abundance levels, and
termini structural conformation were investigatedata source
locationBaltimore and Gaithersburg, Maryland, USAata accessibility Data is provided within this articleD
Value of the data
 Application of top-down and middle-down mass spectrometry for characterization of comprehen-
sive glycosylated protein species from recombinant IgG and IgG-fusion proteins.
 Detection of glycan structure, sites, and relative abundance levels.
 Investigation of termini structural conformation; N-terminal glutamine (Q) to pyroglutamate
(pyroGlu, aka. pE) conversion and C-terminal lysine truncation.
 Improvement on protein sequencing by MALDI ISD, ETD in combination with middle-down
analysis by use of an enzyme, IdeS.1. Data
Glycosylation proﬁling of recombinant IgG and IgG-fusion proteins and sequence coverage
information.2. Experimental design, materials and methods
The recombinant human mAb (IgG1) and IgG1-fusion protein were manufactured using standard
cell culture, puriﬁcation and formulation processes [2]. The IgG1 has two identical light chains and
two identical heavy chains with molecular weight of 150 kDa and N-glycosylation site at N297. The
IgG fusion protein, approximately 90 kDa, was comprised of two chains each with a human protein
domain fused onto the N-terminus of a human IgG1 constant domain (Fc). The protein has three N-
glycosylation sites at N76, N108 and N207.3. Analysis of the IgG protein
The IgG protein was analyzed 1) in reduced form by MALDI-ISD in a 12 T Fourier Transform Ion
Cyclotron Resonance (FT-ICR XR) mass spectrometer (Bruker, Bremen, Germany), and 2) after IdeS
digestion and dithiothreitol (DTT) reduction to generate three smaller fragments; light chain, Fab, and
Fc/2 after which analyzed by LC–MS/MS on an Orbitrap Elite (Thermo Scientiﬁc, Saint Jose, CA, USA).
Fig. 1. MALDI-ISD mass spectrum of the DTT-reduced IgG1 mAb. Amino acid residues underlined were identiﬁed after phase
correction by c or zþ2 ions with a mass error threshold of 50 ppm, covering (A) 37.6% of the light chain and (B) 14.3% of the
heavy chain.
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Fig. 2. LC-MS/MS mass spectrum of IdeS/DDT treated IgG mAb. The charge state distribution of light chain (LC) and Fd domain
are shown. Inset shows the full mass spectrum collected after accumulation of 20 scans over an m/z range 600–3500 at a
resolving power of 120,000.
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Fig. 3. (A) ETD mass spectrum of precursor m/z 1446 (charge 16þ) was searched against IgG1 mAb light chain sequence with
mass tolerance of 100 ppm. ETD mass spectrumwas produced from accumulation of 49 scans. Identiﬁed c- and z- fragment ion
series are indicated in diamonds in the spectrum and relevant sequence identiﬁcation is shown in the sequence. (B) ETD mass
spectrum of precursor m/z 1512 (charge 17þ) was searched against Fd sequence of IgG1 mAb with mass tolerance of 100 ppm.
ETD mass spectrum was produced from accumulation of 50 scans. Identiﬁed c- and z- fragment ion series are indicated in
diamonds in the spectrum and relevant sequence identiﬁcation is shown in the sequence. N-terminal glutamine (Q) to pyr-
oglutamate (pyroGlu) conversion was conﬁrmed with precursor mass error 3.9 ppm (0.10 Da).
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ESI FT-ICR MS as demonstrated in the related study [1].
3.1. MALDI-ISD analysis of reduced protein
The IgG protein in 1 mg/mL in 50 mM ammonium bicarbonate buffer was reduced to light and
heavy chain by 20 mM dithiothreitol (DTT, product 43815, Sigma-Aldrich, St. Louis, MO, USA) at 80 °C
for 15 min. The reduced protein sample was buffer exchanged to 5% acetonitrile (ACN) /0.1% formic
acid (FA) using a 10 kDa molecular weight cut off (MWCO) centrifugal ﬁlter (product UFC201024,
Merck Millipore, Tullagreen, Carrigtwohill, Ireland) and then diluted to 17 mg/mL in 50% ACN/0.1% FA.
1 mL sample and 1 mL of 1,5-diaminonaphthalene (1,5-DAN, product 56451, Fluka, St. Louis, MO, USA)
saturated in ACN were spotted on a stainless steel MALDI plate. MALDI-ISD experiment was per-
formed with a transient domain of 1 mega-word data points (estimated resolving power of 270,000 at
m/z 400) covering m/z range 400–10,000. MALDI-ISD mass spectra after phase correction [3] were
processed to identify c- and zþ2 ions from light chain and heavy chain with mass tolerance 50 ppm
using DataAnalysis 4.2 and Biotools software 3.2 (Bruker) (Fig. 1).
3.2. LC-MS/MS analysis of IdeS-digested protein
The IgG protein was digested with IdeS (product A0-FR1-020, Genovis AB, Lund, Sweden) at a
ratio of 1 unit of enzyme per 1 mg protein for 2 h at 37 °C, followed by DTT treatment. Approximately
14 mg of the IdeS/DTT treated sample was separated on a 100 mm20 mm column packed with
Jupiter 5 mm C5 particles (product 04A-4052, Phenomenex, Torrance, CA, USA) by a fast mobile
gradient of 5–50% ACN/0.1% FA in 15 min at a ﬂow rate of 0.3 mL/min. Light chain and Fd domain
were detected in a range of 350–3500 m/z at resolving power of 120,000 in positive ion mode on the
Orbitrap Elite (Fig. 2). Precursor masses were selected for ETD fragmentation. ETD spectra were
acquired with 5 microscans at resolving power of 120,000 and processed by MASH Suite version
1.0 software [4]. The fragment ions and corresponding sequence coverage are shown in Fig. 3A for the
light chain and Fig. 3B for the Fd domain. Glutamine (Q) to pyroglutamate (pyroGlu) conversion was
conﬁrmed on the N-terminal of heavy chain (Fig. 3B).Fig. 4. Fourier transform ion cyclotron resonance (FT-ICR) mass spectrum of the intact fusion protein peaks (charge 38þ). The
mass spectrum was produced from accumulation of 1650 scans collected in a time domain of 128 K words data points. Major
peaks demonstrate a heterogeneous combination of glycosylation, predominantly by sialic acids (NANA). Additional infor-
mation regarding the glycan nomenclature and structure are provided in Fig. 5.
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The fusion protein was analyzed 1) by accurate mass measured in FT-ICR for protein species
detection 2) by MALDI-ISD following DTT reduction in FT-ICR, and 3) by accurate mass measurement
following IdeS cleavage in FT-ICR or ETD MS/MS in the Orbitrap Elite.
4.1. Accurate mass measurement of intact protein
The fusion protein sample was buffer exchanged to 5%ACN and 0.1%TFA using Amicon 50 kDa
MWCO centrifugal ﬁlters (product UFC505024, Merck Millipore). Since the fusion protein sample was
stored in buffer with detergent, detergent removal was performed by Pierce detergent removal kit
(product 87778, Thermo Scientiﬁc, Rockford, CA, USA). The detergent-free protein sample was
diluted to 10 mg/mL ﬁnal concentration in 50% ACN/0.1% FA and introduced to electrospray ionization
(ESI)-FT-ICR for intact protein mass measurement for detection of protein species. The experiment
was carried out in positive ion mode on the 12 T FT-ICR at ﬂow rate 2 mL/min. Mass spectra were
collected in magnitude mode with a transient domain of 128,000 word data points to cover m/z range
400–4000, with an accumulation of 1650 scans. Fig. 4 shows the protein species detected in m/z
region 2365–2450 with high heterogeneity of glycosylation. Corresponding glycan nomenclature and
structures are shown in Fig. 5.
4.2. MALDI-ISD analysis of reduced protein
The protein sample was diluted to 1 mg/mL in in 50 mM ammonium bicarbonate buffer and reduced
with 20 mM DTT at 80 °C for 15 min. The reduced sample was then detergent removed. TheFig. 5. The glycan nomenclature and structure.
Fig. 6. MALDI-ISD mass spectrum of the DTT reduced fusion protein. Underlined sequence indicates the amino acid residues
identiﬁed by phase-corrected c and/or zþ2 ions, which showed an overall sequence coverage of 25.3% of the full sequence.
Table 1
Glycosylated protein species detected by Fourier transform ion cyclotron resonance (FT-ICR) accurate mass measurement of
DTT/IdeS treated fusion protein from the 17þ charge state. Highlighted in bold are the most abundance glycoforms detected on
the C-terminal fragment of the protein. Additional information regarding the glycan nomenclature and structure are provided
in the Fig. 6.
Potential glycosylated
protein species
Observed m/z Charge (z) Observed monoisotopic
mass [MþH]þ
Theoretical monoisotopic
mass [MþH]þ
Mass error
between
observed and
theoretical
(Da) (ppm)
G0 1479.64124 17þ 25137.77353 25139.397044 1.62 64.58
G0f 1488.28997 17þ 25284.83767 25282.454953 2.38 94.24
G1f 1497.76750 17þ 25445.88614 25444.507776 1.38 54.17
G2f 1507.29477 17þ 25607.90766 25606.560599 1.35 52.61
G1fþNANA 1514.88175 17þ 25736.94787 25735.063193 1.88 73.23
G2fþNANA 1524.41738 17þ 25899.02107 25897.656016 1.37 52.71
G2fþNANA2 1541.54188 17þ 26190.11349 26188.751433 1.36 52.01
B.Q. Tran et al. / Data in Brief 6 (2016) 68–7674detergent-free protein was diluted in 50% ACN/0.1% FA at a ﬁnal concentration of 7 mg/mL. 1 mL of
sample and 1 mL of DAN matrix were spotted on stainless steel MALDI plate. MALDI-ISD mass spectra
were recorded for m/z range 400–10,000 with a transient domain of 1 mega-word data points and
estimated resolving power of 270,000 (at m/z 400). MALDI-ISD spectra were phased corrected and
processed using DataAnalysis and Biotools software. Fragment ions were identiﬁed with mass tol-
erance 50 ppm and sequence coverage of the fusion protein is shown in Fig. 6.
Fig. 7. LC-MS mass spectrum of IdeS/DDT treated fusion protein. Charge state distribution of glycosylated protein species from
of C-terminal fragment is shown. The mass spectrum was produced from accumulation of 20 scans over an m/z range
600–3500 at a resolving power of 120,000.
B.Q. Tran et al. / Data in Brief 6 (2016) 68–76 754.3. ETD MS/MS analysis of IdeS-digested protein
The fusion protein sample was diluted to 1 mg/mL in 50 mM ammonium bicarbonate solution and
digested with enzyme IdeS at ratio of 1 enzyme unit to 1 mg protein for 2 h at 37 °C. 20 mM DDT was
added to cleave disulﬁde bonds at 80 °C for 15 min. The sample was further concentrated using
10 kDa MWCO ﬁlter and subject to detergent removal. The sample buffer was exchanged to 5% ACN/
0.1% FA and diluted to ﬁnal concentration of approximately 7 mg/mL in 50%ACN/0.1% FA. IdeS digestion
and DTT reduction cut the fusion protein to half the size producing N-terminal and C-terminal
fragments.
Accurate mass measurement of the IdeS/DTT treated sample was performed by ESI FT-ICR. Mass
spectra were collected in magnitude mode with a transient domain of one mega-word data points to
cover m/z range 400–4000. Seven glycoforms were identiﬁed from the C-terminus at multiple charge
states. Table 1 represents glycosylated protein species detected from 17þ charge peaks and their
glycan nomenclature and structures are shown in Fig. 5.
The sample was also directly infused into the Orbitrap Elite. Data were collected in positive ion
mode for 350–3500 m/z range at resolving power of 120,000 (Fig. 7). Precursor masses of the gly-
coforms were isolated for ETD fragmentation. ETD mass spectra were acquired with 5 microscans at
resolving power of 120,000 and processed by MASH Suite for sequence coverage analysis. Manual
interpretation of the ETD spectra conﬁrmed that glycosylation by G0f or G1f occurred on a site N207
and the protein has a C-terminal lysine truncation (Fig. 8).
G0f
G0f
G1f
Fig. 8. LC-MS/MS ETD mass spectra of (A) precursor m/z 1266, and (B and C) m/z 1055 were searched against C-terminal
fragment of DTT/IdeS treated fusion protein. Identiﬁed c- and z- fragment ion series are indicated in diamonds in the mass
spectra and relevant sequence identiﬁcations are shown in the associated sequences to the right of each mass spectrum.
Detection of glycosylated protein species, G0f and G1f was conﬁrmed on N207 (in green) with C-terminal lysine truncation.
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